Kim Kelderman, President Diagnostics & Genom at BIO-TECHNE Corp (TECH), sold 845 shares at $424.00 ($358K) on 2021-05-25, disclosed to the SEC on 2021-05-27.
Open-market sale of $358k TECH by President Diagnostics & Genom. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TECH | SELL | 2021-09-24 | $870K | — | Filing → |
| TECH | SELL | 2021-06-11 | $351K | — | Filing → |
| TECH | SELL | 2021-02-09 | $639K | — | Filing → |